- Home
- VNRX vs RENB Comparison
VNRX vs RENB Comparison
Compare VNRX & RENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNRX
- RENB
- Stock Information
- Founded
- VNRX N/A
- RENB 2011
- Country
- VNRX United States
- RENB United States
- Employees
- VNRX N/A
- RENB N/A
- Industry
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- RENB Biotechnology: Pharmaceutical Preparations
- Sector
- VNRX Health Care
- RENB Health Care
- Exchange
- VNRX Nasdaq
- RENB Nasdaq
- Market Cap
- VNRX 52.4M
- RENB 62.0M
- IPO Year
- VNRX N/A
- RENB N/A
- Fundamental
- Price
- VNRX $0.80
- RENB $0.34
- Analyst Decision
- VNRX Strong Buy
- RENB
- Analyst Count
- VNRX 5
- RENB 0
- Target Price
- VNRX $3.88
- RENB N/A
- AVG Volume (30 Days)
- VNRX 307.1K
- RENB 7.5M
- Earning Date
- VNRX 08-13-2025
- RENB 05-15-2025
- Dividend Yield
- VNRX N/A
- RENB N/A
- EPS Growth
- VNRX N/A
- RENB N/A
- EPS
- VNRX N/A
- RENB N/A
- Revenue
- VNRX $1,308,361.00
- RENB N/A
- Revenue This Year
- VNRX $563.72
- RENB N/A
- Revenue Next Year
- VNRX $160.43
- RENB N/A
- P/E Ratio
- VNRX N/A
- RENB N/A
- Revenue Growth
- VNRX 64.16
- RENB N/A
- 52 Week Low
- VNRX $0.40
- RENB $0.27
- 52 Week High
- VNRX $0.94
- RENB $2.10
- Technical
- Relative Strength Index (RSI)
- VNRX 75.61
- RENB 49.44
- Support Level
- VNRX $0.40
- RENB $0.32
- Resistance Level
- VNRX $0.75
- RENB $0.40
- Average True Range (ATR)
- VNRX 0.08
- RENB 0.06
- MACD
- VNRX 0.02
- RENB 0.01
- Stochastic Oscillator
- VNRX 69.33
- RENB 39.67
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
About RENB Renovaro Biosciences Inc.
Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.